Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

被引：0
|
作者：
Simone Gerzeli
Carla Rognoni
Silvana Quaglini
Maria Caterina Cavallo
Giovanni Cremonesi
Alberto Papi
机构：
[1] University of Pavia,Department of Political and Social Sciences
[2] University of Pavia,Laboratory for Biomedical Informatics, Department of Computer Engineering and Systems Science
[3] Bocconi University,Centre for Research on Health and Social Care Management (CERGAS)
[4] Chiesi Farmaceutici S.p.A.,Research Centre on Asthma and COPD
[5] University of Ferrara,undefined
来源：
Clinical Drug Investigation | 2012年 / 32卷
关键词：
Asthma; National Health Service; Probabilistic Sensitivity Analysis; Asthma Management; Successful Control;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Asthma is a chronic disease characterized by acute symptomatic episodes with variable severity and duration. Pharmacological asthma management aims to achieve and maintain control without side effects, thus improving quality of life and reducing the economic impact. Recently, a clinical trial showed the non-inferiority of beclomethasone/formoterol (BDP/F) versus fluticasone propionate/salmeterol (FP/S) in adults with moderate to severe persistent asthma. However, this study did not provide evidence on costs and did not quantify quality-of-life parameters.
引用
收藏
页码：253 / 265
页数：12
相关论文
共 50 条
  • [1] Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma
    Papi, A.
    Paggiaro, P.
    Nicolini, G.
    Vignola, A. M.
    Fabbri, L. M.
    ALLERGY, 2007, 62 (10) : 1182 - 1188
  • [2] Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma II: Study Methodologies
    Willem R. Pieters
    Bo Lundbäck
    Gunnar Johansson
    Mona Palmqvist
    Martin J. Price
    Seema Sondhi
    Robert M.A. Thwaites
    Songkai Yan
    PharmacoEconomics, 1999, 16 : 9 - 14
  • [3] Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma II:: Study methodologies
    Pieters, WR
    Lundbäck, B
    Johansson, G
    Palmqvist, M
    Price, MJ
    Sondhi, S
    Thwaites, RMA
    Yan, SK
    PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 9 - 14
  • [4] Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma I: Introduction and Overview
    Bo Lundbäck
    Willem R. Pieters
    Gunnar Johansson
    Mona Palmqvist
    Martin J. Price
    Seema Sondhi
    Robert M.A. Thwaites
    PharmacoEconomics, 1999, 16 : 1 - 8
  • [5] Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma
    Doull, Lolo
    Price, David
    Thomas, Mike
    Hawkins, Neil
    Stamuli, Eugena
    Tabberer, Maggie
    Gosden, Toby
    Rudge, Helen
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1147 - 1159
  • [6] COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada
    Ismaila, Afisi S.
    Risebrough, Nancy
    Li, Chunmei
    Corriveau, Diane
    Hawkins, Neil
    FitzGerald, J. Mark
    Su, Zhen
    RESPIRATORY MEDICINE, 2014, 108 (09) : 1292 - 1302
  • [7] Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma
    Richard D. O’Connor
    Harold Nelson
    Rohit Borker
    Amanda Emmett
    Priti Jhingran
    Kathleen Rickard
    Paul Dorinsky
    PharmacoEconomics, 2004, 22 : 815 - 825
  • [8] Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma
    Ericsson, K
    Bantje, TA
    Huber, RM
    Borg, S
    Bateman, ED
    RESPIRATORY MEDICINE, 2006, 100 (04) : 586 - 594
  • [9] Cost-effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients
    Tohda, Yuji
    Nishima, Sankei
    Arakawa, Ichiro
    Shiragami, Makoto
    Miyamoto, Terumasa
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (04): : 593 - 603
  • [10] Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial
    Pertseva, Tetyana
    Dissanayake, Sanjeeva
    Kaiser, Kirsten
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (10) : 1357 - 1390
12345